From cancer patients to cancer survivors: The issue of Cardioncology - A biological perspective

European Journal of Cancer

Volumn 46, Issue 4, 2010, Pages 697-702

  Zambelli, Alberto ^a   Porta, Matteo Della ^b   Rosti, Vittorio ^c  

^a Unit of Nephrology and Dialysis   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cancer survivors; Cardioncology; Cardiotoxicity; Endothelial progenitor cells

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CD34 ANTIGEN; JANUS KINASE 2; LAPATINIB; PROTEIN TYROSINE KINASE INHIBITOR; SORAFENIB; SUNITINIB; TRASTUZUMAB; VASCULOTROPIN RECEPTOR 2;

ARTICLE; CANCER GROWTH; CANCER RESEARCH; CANCER SURVIVAL; CANCER SURVIVOR; CARDIOLOGY; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; ENDOTHELIUM CELL; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ONCOLOGY; PRIORITY JOURNAL; STEM CELL; TUMOR VASCULARIZATION;

ANTINEOPLASTIC AGENTS; CARDIOVASCULAR DISEASES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASM METASTASIS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STEM CELLS;

EID: 76049084088     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.12.011     Document Type: Article

References (60)

1. Sant M., Allemani C., Santaquilani M., Knijn A., and Marchesi F. Capocaccia R; EUROCARE Working Group. EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary. Eur J Cancer 45 (2009) 931-991
2. Carver J.R., Shapiro C.L., Ng A., et al. For the ASCO Cancer Survivorship expert panel. American Society of Clinical Oncology clinical evidence review of the ongoing care of adult cancer survivors: cardiac and pulmonary late effects. J Clin Oncol 25 (2007) 3991-4008
3. Jensen B.V. Cardiotoxic consequences of anthracycliune-containing therapy in patients with breast cancer. Semin Oncol 33 (2006) S15-S21
4. Chen M.H., Kerkelä R., and Force T. Mechanism of cardiac dysfunction associated with tyrosin kinase inhibitor cancer therapeutics. Circulation 118 (2008) 84-95
5. Gianni L., Herman E.H., Lipshultz S.E., Minotti G., Sarvazyan N., and Sawyer D.B. Anthracycline cardiotoxicity: from bench to bedside. J Clin Oncol 26 (2008) 3777-3784
6. Daher I.N., and Yeh T.H. Vascular complications of selected cancer therapies. Nat Clin Pract Cardiovasc Med 5 (2008) 797-805
7. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 2759 5302 (1997) 964-967
8. Heil M., Eitenmuller I., Schmitz-Rixen T., and Schaper W. Arteriogenesis versus angiogenesis: similarities and differences. J Cell Mol Med 10 (2006) 45-55
9. Liew A., Barry F., and O'Brien T. Endothelial progenitor cells: diagnostic and therapeutic considerations. Bioessays 28 (2006) 261-270
10. Case J., Mead L.E., Besler W.K., et al. Human CD34+, AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. J Exp Hematol 35 (2007) 1109-1118
11. Mancuso P., Antoniotti P., Quarna J., et al. Validation of a standardized method for enumerating circulating endothelial cells and progenitors: flow cytometry and molecular and ultrastructural analyses. Clin Cancer Res 15 (2009) 267-273
12. Hill J.M., Zakos G., Halcox J.P., et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. New Engl J Med 348 (2003) 593-600
13. Yoder M.C., Mead L.E., Prater D., et al. Re-defining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109 (2007) 1801-1809
14. Piaggio G., Rosti V., Corselli M., et al. Endothelial colony forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker. Blood 114 (2009) 3127-3130
15. Urbich C., and Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95 (2004) 343-353
16. Rehman J., Li J., Orschell C.M., and March K.L. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic factors. Circulation 107 (2003) 1164-1169
17. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci USA 97 (2000) 3422-3427
18. Prokopi M., Pula G., Mayr U., et al. Proteomic amalysis reveals the presence of platelet microparticles in endothelial progenitor cell cultures. Blood 114 (2009) 723-732
19. Assmus B., Schachinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
20. Assmus B., Honold J., Schachinger V., et al. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 355 (2006) 1222-1232
21. Ingram D.A., Mead L.E., Tanaka H., et al. Identification of a novel hyerarchy of endothelial progenitor cells using human peripheral and umilical cord blood. Blood 104 (2004) 2752-2760
22. Reinisch A., Hofmann N.A., Obenauf A.C., et al. Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. Blood 113 (2009) 6716-6725
23. Yoon C.H., Hur J., Park K.W., et al. Synergistic neovascularization by mixed transplantation of early endothelial progenitor cells and late outgrowth endothelial cells: the role of angiogenic cytokines and matrix metalloproteinases. Circulation 112 (2005) 1618-1627
24. Sieveking D.P., Buckle A., Celermajer D.S., and Ng M.K.C. Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insight from a novel human angiogenesis assay. J Am Coll Cardiol 51 (2008) 660-668
25. Ziegelhoeffer T., Fernandez B., Kostin S., et al. Bone marrow derived cells do not incorporate into the adult growing vasculature. Circ Res 94 (2004) 230-238
26. Grunewald M., Avraham I., Dor Y., et al. VEGF-induced adult neovascularization: recruitment, retention, and role of accesory cell. Cell 124 (2006) 175-189
27. Hanahan D., and Folkman J. Pattern and emerging mechanism of the angiogenic switch during tumourigenesis. Cell 86 (1996) 353-364
28. Gao D., Nolan D.J., Mellick A.S., Bambino K., McDonnell K., and Mittal V. Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis. Science 319 (2008) 195-198
29. Lyden D., Hattori K., Dias S., et al. Impaired recruitment of bone marrow-derived endothelial and hematopoietic precursors blocks tumour angiogenesis and growth. Nature Med 7 (2001) 1194-1201
30. Nolan D.J., Ciarrocchi A., Mellick A.S., et al. Bone marrow derived endothelial progenitor cells are a major determinant of nascent tumour vascularization. Genes Dev 21 (2007) 1546-1558
31. Kaplan R.N., Riba R.D., Zacharoulis S., et al. VEGFR-1 positive hematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438 (2005) 820-827
32. Ingram D.A., et al. Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105 (2005) 2783-2786
33. Ergün S., Hohn H.P., Kilic N., Singer B.B., and Tilki D. Endothelial and hematopoietic progenitor cells (EPC and HPC): hand in hand fate determining partners for cancer cells. Stem Cell Rev 4 (2008) 169-177
34. Murdoch C., Muthana M., Coffelt S.B., and Lewis C.E. The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer 8 (2008) 618-631
35. De Palma M., Venneri M.A., Roca C., and Naldini L. Targeting exogenous genes to tumour angiogenesis by transplantation of genetically modified hematopoietic stem cells. Nat Med 9 (2003) 789-795
36. Gothert J.R., et al. Genetically tagging endothelial cells in vivo: bone marrow-derived cells do not contribute to tumour endothelium. Blood 104 (2004) 1769-1777
37. Purhonen S., Palm J., Rossi D., et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumour growth. Proc Natl Acad Sci USA 105 (2008) 6620-6625
38. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
39. Bertolini F., Shaked Y., Mancuso P., and Kerbel R.S. The multifaceted circulating endothelial cell in cancer: towards marker and target identification. Nat Rev Cancer 6 (2006) 835-845
40. Maniotis A.J., Folberg R., Hess A., et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am J Pathol 155 (1999) 739-752
41. Gunsilius E., Duba H.C., Petzer A.L., et al. Evidence from a leukemia model for maintenance of vascular endothelium by bone marrow-derived endothelial cells. Lancet 355 (2000) 1688-1691
42. Oppliger Leibungudt E., Horn M.P., et al. Hematopoietic and endothelial progenitor cell trafficking in patients with myeloproliferative diseases. Haematologica 91 (2006) 1465-1472
43. Zhang H., Vakil V., Braunstein M., et al. Circulating endothelial progenitor cells in multiple myeloma: implications and significance. Blood 105 (2005) 3286-3294
44. Pompilio G., Capogrossi M.C., Pesce M., et al. Endothelial progenitor cells and cardiovascular homeostasis: clinical implications. Int J Cardiol 131 (2009) 156-167
45. Vasa M., Fichtlscherer S., Aicher A., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery diseases. Circ Res 89 (2001) E1-E7
46. Schmidt-Lucke C., Rossig L., Fichtlscherer S., et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events. Proof of concept for the clinical importance of cardiovascular repair. Circulation 111 (2005) 2981-2987
47. Werner N., Kosiol S., Schiegl T., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353 (2005) 999-1007
48. Kunz G.A., Liang G., Kukuloski F., et al. Circulating endothelail progenitor cells predict coronary artery disease severity. Am Heart J 152 (2006) 190-195
49. Massa M., Rosti V., Ferrario M., et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 105 (2005) 199-206
50. Guven H., Shepherd R.M., Bach R.G., Capoccia B.J., and Link D.C. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J Am Coll Cardiol 48 (2006) 1579-1587
51. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients wth acute myocardial infarction. Circulation 103 (2001) 2776-2779
52. Leone M., Rutella S., Bonanno G., et al. Mobilization of bone marrow derived stem cells after myocardial infarction and left ventricular function. Eur Heart J 26 (2005) 1196-1204
53. Wojakowski W., Tendera M., Zebzda A., et al. Mobilization of CD34+, CD117+, CXCR4+, c-met+ stem cells is correlated with left ventricular ejection fraction and plasma NT-proBNP levels in patients wirth acute myocardial infarction. Eur Heart J 27 (2006) 283-289
54. Massa M., Campanelli R., Bonetti E., Ferrario M., Marinoni B., and Rosti V. Rapid and large increase of the frequency of circulating endothelail colony forming cells (ECFCs) generating late outgrowth endothelial cells in patients with acute myocardial infarction. Exp Hematol 37 (2009) 8-9
55. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone marrow derived angioblasts prevents cardiomyocytes apoptosis, reduces remodeling, and improves cardiac function. Nat Med 7 (2001) 430-436
56. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
57. Yoshioka T., Ageyama N., Shibata H., et al. Repair of infarcted myocardium mediated by transplanted bone marrow derived CD34+ stem cells in a nonhuman primate model. Stem cells 23 (2005) 355-364
58. Kawamoto A., Tkebuchana T., Yamaguchi J., et al. Intramyocardial translantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial hischemia. Circulation 107 (2004) 461-468
59. Krenning G., van Luyn M.J.A., and Harmsen M.C. Endothelial progenitor cell-based neovascularization: implications for therapy. Trends Vasc Med 15 (2009) 180-189
60. Sekiguchi H., Masaaki I.I., and Losordo W.D. The relative potency and safety of endothelial progenitor cells and unselected mononuclear cells for recovery from myocardial infarction and ischemia. J Cell Physiol 219 (2009) 235-242